Projects per year
Personal profile
Biography
I am a Medical Oncologist working with the Oncology Clinical Trials Program at Cabrini Health, specifically focusing on upper and lower gastrointestinal trials. I am passionate about providing empathic, patient-centred care and getting patients onto clinical trials.
I am also working with Cabrini's Department of Surgery's Research Team to harness natural synergies between oncological and surgical research programs. I have been involved in the development and implementation of a cell-free DNA collection protocol for upper GI tract cancers while completing a Canadian fellowship, translational research in upper and lower GI tumours within a whole genome sequencing program, as well as clinical outcomes research and quality improvement in clinical trials.
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Research area keywords
- Clinical trials
- Oncology
- GI tract cancers
- Lower GI tumours
- Whole genome sequencing
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
A Phase 1a/1b, First-in-Human, Open Label Study to Assess the Safety, Tolerability, and Pharmacokinetics of PMC-309 (Anti-VISTA), as Monotherapy and Combined with Pembrolizumab, in Patients with Advanced or Metastatic Solid Tumors
Mendis, S. (Primary Chief Investigator (PCI))
7/12/23 → 6/12/25
Project: Research
-
A Phase II open label, dose-finding run-in and cohort expansion study to evaluate the safety, tolerability and effectiveness of AUM001 in combination with pembrolizumab or irinotecan in metastatic colorectal cancer
Mendis, S. (Primary Chief Investigator (PCI))
27/04/23 → 26/04/26
Project: Research
-
An Open, Multi-center, Phase I Clinical Study of ATG-022 in Patients with Advanced/metastatic Solid Tumors
Mendis, S. (Primary Chief Investigator (PCI))
23/01/23 → 22/01/26
Project: Research
-
Phase 1/2 Safety and Efficacy Study of NUV-868 as Monotherapy and in Combination with Olaparib or Enzalutamide in Adult Patients with Advanced Solid Tumors
Mendis, S. (Primary Chief Investigator (PCI))
11/08/23 → 11/08/25
Project: Research
-
A Phase 1/2 Study of BMS-986340 as Monotherapy and in Combination with Nivolumab or Docetaxel in Participants with Advanced Solid Tumors
Mendis, S. (Primary Chief Investigator (PCI))
14/06/23 → 13/06/25
Project: Research